US 7,582,314 B2, AU2004322710B2, CN101132693, EP1791423B1
Composition and methods for the management
AU2011200854B2
Composition for down-regulating pro-inflammatory markers
CA2732915C
Composition comprising boswellic acid for downregulating/inhibiting pro-inflammatory markers
EA023717B1
Use of a composition for down-regulating/inhibiting PGE2
IN238950
A process of preparing a synergistic composition for treating hyperproliferative dermatological conditions
JP4820819B2, NZ552027A, RU2366412C2, ZA200700694B